Through proteomics and bioinformatics analyses of PRCC, we found that high‐mobility group protein A2 (HMGA2) was highly expressed in tumor tissues, and patients with high HMGA2 expression exhibited shorter survival times. The gene discussed is PRCC; the disease is neoplasm.